LioCyx-M

HBV-TCR T cell therapy · Lion TCR Pte. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LioCyx-M, covering 2025-05-08 to 2025-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma [Phase 1]